Review: taking Citalopram hydrobromide and Seroquel together


Summary

Drug interactions are reported among people who take Citalopram hydrobromide and Seroquel together. This review analyzes the effectiveness and drug interactions between Citalopram hydrobromide and Seroquel. It is created by eHealthMe based on reports of 5,599 people who take the same drugs from FDA and social media, and is updated regularly.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Citalopram Hydrobromide

Citalopram hydrobromide has active ingredients of citalopram hydrobromide. It is often used in depression. (latest outcomes from Citalopram hydrobromide 25,688 users)

Seroquel

Seroquel has active ingredients of quetiapine fumarate. It is often used in bipolar disorder. (latest outcomes from Seroquel 89,713 users)

On Sep, 16, 2016

5,599 people who take Citalopram Hydrobromide, Seroquel are studied.


Number of reports submitted per year:

Citalopram hydrobromide and Seroquel drug interactions.

Drug effectiveness over time:

Citalopram Hydrobromide:
  • < 1 month: 0.0% - (0 of 5 people)
  • 1 - 6 months: 16.0% - (4 of 25 people)
  • 6 - 12 months: 23.0% - (4 of 17 people)
  • 1 - 2 years: 38.0% - (13 of 34 people)
  • 2 - 5 years: 35.0% - (11 of 31 people)
  • 5 - 10 years: 52.0% - (10 of 19 people)
  • 10+ years: 42.0% - (3 of 7 people)
  • not specified: 0.0% - (0 of 1 people)
Seroquel:
  • < 1 month: 17.0% - (3 of 17 people)
  • 1 - 6 months: 30.0% - (12 of 39 people)
  • 6 - 12 months: 57.0% - (11 of 19 people)
  • 1 - 2 years: 54.0% - (12 of 22 people)
  • 2 - 5 years: 46.0% - (12 of 26 people)
  • 5 - 10 years: 42.0% - (6 of 14 people)
  • 10+ years: 60.0% - (3 of 5 people)
  • not specified: 0.0% - (0 of 2 people)

Drug effectiveness by gender:

Citalopram Hydrobromide:
  • female: 34.0% - (35 of 101 people)
  • male: 26.0% - (10 of 38 people)
Seroquel:
  • female: 39.0% - (41 of 103 people)
  • male: 43.0% - (18 of 41 people)

Drug effectiveness by age:

Citalopram Hydrobromide:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 1 people)
  • 10-19: 41.0% - (5 of 12 people)
  • 20-29: 25.0% - (6 of 24 people)
  • 30-39: 28.0% - (11 of 38 people)
  • 40-49: 37.0% - (12 of 32 people)
  • 50-59: 39.0% - (9 of 23 people)
  • 60+: 22.0% - (2 of 9 people)
Seroquel:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 1 people)
  • 10-19: 46.0% - (7 of 15 people)
  • 20-29: 45.0% - (11 of 24 people)
  • 30-39: 39.0% - (15 of 38 people)
  • 40-49: 50.0% - (16 of 32 people)
  • 50-59: 28.0% - (7 of 25 people)
  • 60+: 33.0% - (3 of 9 people)

Most common drug interactions over time *:

< 1 month:
  • suicide attempt
  • loss of consciousness
  • somnolence
  • depression
  • type 2 diabetes mellitus
  • agitation
  • fall
  • restlessness
  • diabetes mellitus
  • dizziness
1 - 6 months:
  • type 2 diabetes mellitus
  • diabetes mellitus
  • weight increased
  • diabetes mellitus inadequate control
  • anxiety
  • suicidal ideation
  • blood cholesterol increased
  • neuropathy peripheral
  • hyperlipidaemia
  • insomnia
6 - 12 months:
  • type 2 diabetes mellitus
  • diabetes mellitus
  • neuropathy peripheral
  • agitation neonatal
  • neonatal respiratory distress syndrome
  • type 1 diabetes mellitus
  • gestational diabetes
  • diabetic neuropathy
  • diabetes mellitus inadequate control
  • blood cholesterol increased
1 - 2 years:
  • type 2 diabetes mellitus
  • diabetes mellitus
  • blood cholesterol increased
  • diabetes mellitus inadequate control
  • insomnia
  • depression
  • hyperlipidaemia
  • diabetic neuropathy
  • fatigue
  • obesity
2 - 5 years:
  • type 2 diabetes mellitus
  • diabetes mellitus
  • obesity
  • blood cholesterol increased
  • diabetic neuropathy
  • hyperglycaemia
  • diabetes mellitus inadequate control
  • weight increased
  • insomnia
  • hypoglycaemia
5 - 10 years:
  • type 2 diabetes mellitus
  • diabetes mellitus
  • blood cholesterol increased
  • hyperlipidaemia
  • obesity
  • diabetic neuropathy
  • type 1 diabetes mellitus
  • weight increased
  • hyperglycaemia
  • back pain
10+ years:
  • diabetes mellitus
  • type 2 diabetes mellitus
  • pain
  • neuropathy peripheral
  • fall
  • fatigue
  • insomnia
  • blood cholesterol increased
  • dizziness
  • musculoskeletal discomfort
not specified:
  • insomnia
  • diabetes mellitus
  • type 2 diabetes mellitus
  • drug ineffective
  • somnolence
  • blood cholesterol increased
  • depression
  • anxiety
  • gastrooesophageal reflux disease
  • malaise

Most common drug interactions by gender *:

female:
  • insomnia
  • type 2 diabetes mellitus
  • blood cholesterol increased
  • diabetes mellitus
  • drug ineffective
  • somnolence
  • gastrooesophageal reflux disease
  • dizziness
  • vomiting
  • fatigue
male:
  • diabetes mellitus
  • insomnia
  • type 2 diabetes mellitus
  • anxiety
  • depression
  • tremor
  • suicidal ideation
  • weight increased
  • malaise
  • weight decreased

Most common drug interactions by age *:

0-1:
  • neonatal respiratory distress syndrome
  • agitation neonatal
  • foetal exposure during pregnancy
  • premature baby
  • drug withdrawal syndrome neonatal
  • feeding disorder neonatal
  • restlessness
  • temperature regulation disorder
  • maternal drugs affecting foetus
  • cerebral cyst
2-9:
  • acute stress disorder
  • adverse drug reaction
  • anxiety
  • asthenia
  • bronchitis
  • confusional state
  • crying
  • drug withdrawal syndrome
  • feeling abnormal
  • hypoproteinaemia
10-19:
  • drug ineffective
  • depression
  • pain
  • suicidal ideation
  • chest pain
  • gastrooesophageal reflux disease
  • malaise
  • dyspepsia
  • panic attack
  • weight increased
20-29:
  • type 2 diabetes mellitus
  • depression
  • insomnia
  • drug ineffective
  • blood cholesterol increased
  • somnolence
  • suicidal ideation
  • vomiting
  • diabetes mellitus
  • anxiety
30-39:
  • diabetes mellitus
  • type 2 diabetes mellitus
  • weight increased
  • diabetes mellitus inadequate control
  • obesity
  • blood cholesterol increased
  • hyperglycaemia
  • suicidal ideation
  • depression
  • pancreatitis
40-49:
  • insomnia
  • type 2 diabetes mellitus
  • blood cholesterol increased
  • diabetes mellitus
  • gastrooesophageal reflux disease
  • adverse event
  • disturbance in attention
  • drug ineffective
  • somnolence
  • vomiting
50-59:
  • type 2 diabetes mellitus
  • diabetes mellitus
  • insomnia
  • blood cholesterol increased
  • diabetes mellitus inadequate control
  • anxiety
  • weight increased
  • hyperglycaemia
  • diabetic neuropathy
  • neuropathy peripheral
60+:
  • insomnia
  • malaise
  • fall
  • anxiety
  • somnolence
  • fatigue
  • depression
  • dizziness
  • agitation
  • drug ineffective

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Citalopram hydrobromide and Seroquel?

Can you answer these questions?

More questions for: Citalopram hydrobromide, Seroquel

You may be interested in these reviews

More reviews for: Citalopram hydrobromide, Seroquel

On eHealthMe, Citalopram hydrobromide (citalopram hydrobromide) is often used to treat depression. Seroquel (quetiapine fumarate) is often used to treat bipolar disorder. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.